Interesting, what are your thoughts on the anti-CD47 investigational therapeutics being tested for cancer indications? How do you think that antagonizing CD47 will impact this 'system maintenance'. Do you think that modulating autophagy is part of the problem of enhanced autoimmunity, since its clear that is involved in immune surveillance? There is a lot of science out there around this area.